Before visiting, please review our current visitor policies and COVID-19 information.
Castle Biosciences Inc. CBI_2021_OSCC_DevVal_1
Trial Overview
Official Title
Development and Validation of a Gene Expression Assay to Predict the Risk of Disease Progression in Oral Squamous Cell Carcinoma
Study Purpose
This is a retrospective review of medical records and archived pathology material.
Diagnosis
Oral Squamous Cell CarcinomaEligibility
The specimens requested are from patients who have already received standard of care treatment.
Intervention
No treatment arms.
For more information visit clinicaltrials.gov
Key Participation Requirements
Trial Location(s)
Gender
Male or Female
Age
18 years and Older
Enrollment Status
Recruiting
Phase
Not Applicable
Methodist Health System Trial Code
CBI_2021_OSCC_DevVal_1